StockStory Flags Clorox’s Sales and Cash-Flow Weaknesses
The publisher points to declining sales, modest organic growth and a lower free-cash-flow margin in its cautious assessment of Clorox.
Makkler Newsroom · Oct 13, 12:31 AM · 1 min read
Market closed· · AUD · Data may be delayed
Avg. target AUD 3.58 (+34.1%)
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.